Home4016 • TADAWUL
add
Middle East Pharmaceutical Inds Co SJSC
Previous close
SAR 97.80
Day range
SAR 96.50 - SAR 97.80
Year range
SAR 94.30 - SAR 139.00
Market cap
1.94B SAR
Avg Volume
49.12K
P/E ratio
20.04
Dividend yield
2.49%
Primary exchange
TADAWUL
Market news
Financials
Income Statement
Revenue
Net income
| (SAR) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 137.52M | 1.12% |
Operating expense | 43.77M | 3.77% |
Net income | 44.52M | -0.64% |
Net profit margin | 32.38 | -1.73% |
Earnings per share | — | — |
EBITDA | 49.70M | 0.35% |
Effective tax rate | 3.07% | — |
Balance Sheet
Total assets
Total liabilities
| (SAR) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 34.37M | 51.77% |
Total assets | 599.53M | 13.81% |
Total liabilities | 183.29M | 15.59% |
Total equity | 416.24M | — |
Shares outstanding | 20.00M | — |
Price to book | 4.70 | — |
Return on assets | 19.93% | — |
Return on capital | 25.41% | — |
Cash Flow
Net change in cash
| (SAR) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 44.52M | -0.64% |
Cash from operations | 10.50M | -48.94% |
Cash from investing | -5.86M | -20.05% |
Cash from financing | 2.52M | 136.85% |
Net change in cash | 7.16M | -18.92% |
Free cash flow | -2.86M | -166.68% |
About
Founded
1998
Headquarters
Website
Employees
632
